In Vitro Synergistic Inhibition and Eradication of Pathogenic Bacterial Biofilms by Bacillus subtilis-derived Anti-biofilm Enzymes

View at publisher Summarise with VIRAT
Authors: Ayisha Aman, Mawa Naeem, Fiza Khan, Khadeeja Qadeer, Raheela Rahmat Zohra, Mahnaz Ahmad
Cited by: 0
References: 84

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Biofilm formation is a crucial virulent attribute of pathogens that promotes their resistance to antibiotics and contributes to chronic illnesses in humans. Traditional antibiotic therapies have proven ineffective in eliminating sessile microbial populations within biofilms, necessitating the development of novel therapeutic strategies. In this study, an in vitro efficacy of the antibiofilm enzymes derived from Bacillus subtilis was evaluated against biofilm-forming human clinical pathogens. METHODS: An in vitro impact of combined anti-biofilm enzymes obtained from Bacillus subtilis C5W on the inhibition and eradication of biofilms of Acinetobacter baumannii, Enterobacter aerogenes, and Escherichia coli was monitored using a spectrophotometric microtiter plate assay. RESULTS: Among seven clinical pathogens, three pathogens were found to be strong biofilm producers as they formed biofilm at an incubation time of 48 hours. The anti-biofilm enzymes significantly inhibited the biofilm formation of Acinetobacter baumannii and Enterobacter aerogenes at an incubation time of 48 hours, with inhibition rates of 62.51% and 57.91%, respectively. In contrast, the maximum inhibition of biofilm formation in Escherichia coli was observed at 24 hours, with an inhibition rate of 76.69%. The biofilm eradication rates were recorded to be 30.17% (Acinetobacter baumannii), 46.29% (Enterobacter aerogenes), and 53.02% (Escherichia coli) after a 24-hour incubation time. The SEM images confirmed the disruption of adhered biofilm on the glass surface and aggregation of microcolonies. DISCUSSION: The study highlighted that Bacillus subtilis-derived enzyme combinations showed a synergistic inhibitory effect against biofilms formed by human clinical pathogens under in vitro conditions. The combined enzymatic treatment not only disrupted established biofilms but also suppressed their formation, indicating an enhanced anti-biofilm potential. CONCLUSION: These findings demonstrated the multi-enzyme approach as a promising and effective alternative to conventional antimicrobial approaches for managing biofilm-associated infections.

Fields of Study & Subjects

Bacterial biofilms and quorum sensing Biochemical and Structural Characterization Bacteriophages and microbial interactions

Publication details

Journal / source
Current Protein and Peptide Science
Volume
27
Issue
9
Pages
858–870
Publication date
20 March 2026
Language
EN